日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase I Trial of Evorpacept, Lenalidomide and Rituximab for Patients with B-cell Non-Hodgkin Lymphoma.

Evorpacept、来那度胺和利妥昔单抗治疗 B 细胞非霍奇金淋巴瘤患者的 I 期试验

Strati Paolo, Feng Lei, Tyshevich Andrey, Shavronskaya Darya, Alesse Julia, English Noel, Sheehan Elizabeth, Syzrantsev Nikita, Nesmelov Alexander, Zhuang Tony Z, Chihara Dai, Westin Jason R, Ahmed Sairah, Fayad Luis E, Henderson Jared, Dent Kylie, McChesney Elizabeth, Neelapu Sattva S, Flowers Christopher R